Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Verve Therapeutics Inc VERV

Healthcare Biotechnology
Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Company’s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering... see more

Recent & Breaking News (NDAQ:VERV)

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Verve Therapeutics, Inc. - VERV

Business Wire August 27, 2024

The Schall Law Firm Urges Investors To Join An Investigation Into Whether Verve Therapeutics Inc Committed Securities Law Infractions

Accesswire August 26, 2024

Verve Therapeutics Inc Is Being Inquired Into For Potential Securities Law Violations And The Schall Law Firm Is Seeking Shareholders To Participate

Accesswire August 25, 2024

The Schall Law Firm Invites Investors In Verve Therapeutics Inc To Join The Securities Fraud Investigation

Accesswire August 24, 2024

The Schall Law Firm Is Inquiring Into Verve Therapeutics Inc For Potential Securities Law Violations And Stockholders Are Encouraged To Participate

Accesswire August 23, 2024

Verve Therapeutics Inc Is Being Investigated By The Schall Law Firm For Possible Securities Fraud And Investors Are Invited To Assist

Accesswire August 22, 2024

The Schall Law Firm Is Investigating Verve Therapeutics Inc For Potential Securities Law Violations And Seeks Shareholders' Involvement

Accesswire August 21, 2024

Verve Therapeutics Inc Is Being Investigated By The Schall Law Firm For Possible Securities Violations And Wants Shareholders To Participate

Accesswire August 20, 2024

The Schall Law Firm Is Inquiring Into Allegations Against Verve Therapeutics Inc For Securities Violations And Wants Investors To Join

Accesswire August 19, 2024

The Schall Law Firm Is Investigating Allegations Against Verve Therapeutics Inc And Wants Investors To Help

Accesswire August 18, 2024

The Schall Law Firm Is Inquiring Into Allegations Against Verve Therapeutics Inc And Seeks Shareholders To Join

Accesswire August 17, 2024

The Schall Law Firm Is Investigating Verve Therapeutics Inc And Seeks Investors With Losses To Join

Accesswire August 16, 2024

The Schall Law Firm Is Looking Into Verve Therapeutics Inc And Invites Investors With Losses To Reach Out

Accesswire August 15, 2024

The Schall Law Firm Is Investigating Verve Therapeutics Inc And Encourages Investors With Losses To Reach Out

Accesswire August 14, 2024

The Schall Law Firm Is Probing Verve Therapeutics Inc And Motivates Investors With Losses To Reach Out

Accesswire August 13, 2024

Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact

Accesswire August 12, 2024

Verve Therapeutics Inc Is Being Probed By The Schall Law Firm Which Urges Investors With Losses To Reach Out

Accesswire August 9, 2024

Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Make Contact

Accesswire August 8, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verve Therapeutics, Inc. (NASDAQ: VERV)

PR Newswire August 8, 2024

Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV

PR Newswire August 8, 2024